v3.26.1
Related Party Transactions (Tables)
 6 Months Ended
Jun. 30, 2026
Related Party Transactions [Abstract]  
Schedule of Allocations for Statements of Operations

For the three and six months ended June 30, 2026 and 2025, transactions with AnaptysBio were as follows:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

(in thousands)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Research and development

 

$

 

1,853

 

 

$

 

13,129

 

 

$

 

17,166

 

 

$

 

26,816

 

General and administrative

 

$

 

3,664

 

 

$

 

6,626

 

 

$

 

22,520

 

 

$

 

16,441

 

Total allocated operating expenses

 

$

 

5,517

 

 

$

 

19,755

 

 

$

 

39,686

 

 

$

 

43,257

 
Schedule of Reconciliation Amount Presented on the Combined Statements of Cash Flows The components of net transfers from AnaptysBio and the reconciliation to the corresponding amount presented on the statements of cash flows, for the six months ended June 30, 2026 and 2025, were as follows:

 

(in thousands)

 

2026

 

 

2025

 

Allocations of AnaptysBio's corporate expenses

 

$

 

9,077

 

 

$

 

(46,389

)

Non-cash transfer of investments to AnaptysBio

 

 

 

37,986

 

 

 

 

—

 

Non-cash transfer of ROU assets to AnaptysBio

 

 

 

12,886

 

 

 

 

—

 

Non-cash transfer of lease liabilities to AnaptysBio

 

 

 

(14,112

)

 

 

 

—

 

Non-cash transfer of other current assets to AnaptysBio

 

 

 

6,048

 

 

 

 

—

 

Non-cash transfer of accrued liabilities to AnaptysBio

 

 

 

(28,797

)

 

 

 

—

 

Total

 

$

 

23,088

 

 

$

 

(46,389

)